Stay updated on Venetoclax in FLAMSA + Treosulfan for Allo SCT Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in FLAMSA + Treosulfan for Allo SCT Clinical Trial page.

Latest updates to the Venetoclax in FLAMSA + Treosulfan for Allo SCT Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.3 was added to the page. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new software revision entry (v3.3.2) is added to the record history, replacing the previous v3.2.0; no study data or essential content were modified; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe government funding/operating status notice at the top of the page was removed. The page now presents only the study record history and related content without that banner.SummaryDifference0.8%

- Check60 days agoChange DetectedNo substantive changes to the study record are visible; the page content and status sections appear the same across versions, with only minor layout/visual updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedMajor upgrade: version bumped to v3.2.0 and a prominent funding/operating-status notice added; previous v3.1.0 reference removed.SummaryDifference13%

- Check89 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Venetoclax in FLAMSA + Treosulfan for Allo SCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in FLAMSA + Treosulfan for Allo SCT Clinical Trial page.